DrugDashboards

Market view

erythromycin ethylsuccinate · Powder

4 marketed package NDCs · 3 active manufacturers

Most dispensed: 400 mg/5mL · Suspension · #100 mL/bottle · 200 mg/5mL · Granule, For Suspension · #100 mL/bottle · 200 mg/5mL · Suspension · #100 mL/bottle · 200 mg/5mL · Granule, For Suspension · #200 mL/bottle

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately.

What changed in the last 90 days

Every detected change for erythromycin ethylsuccinate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Macrolide, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Erythromycin ethylsuccinate in shortage right now?
No. FDA does not currently list Erythromycin ethylsuccinate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Erythromycin ethylsuccinate?
12 companies have marketed Erythromycin ethylsuccinate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Erythromycin ethylsuccinate cost?
The typical pharmacy pays about $1.53 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.